Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jun 2021 · 1 min read
In brief
In brief
Retrospective study of 29 pediatric hepatoblastoma patients demonstrates indocyanine green fluorescence achieves 91% sensitivity for detecting primary and metastatic disease during surgical resection, identifying occult lesions missed on preoperative imaging in 10% of cases. ICG-guidance enabled margin delineation during liver resection and localized multifocal disease, though 43% false-positive rate limits specificity.
Written by the GCMD Library team from the article.
Statements in this article
Hepatoblastoma is the most common primary pediatric liver malignancy.
ICG sensitivity was 91% for 120 resected thoracic specimens from 21 patients with hepatoblastoma.
ICG specificity was 57% for resected thoracic specimens in hepatoblastoma.
In 10% of operations, hepatoblastoma-positive specimens were resected solely based on ICG-avidity.
In 40% of cases, ICG assisted in localizing a preoperatively diagnosed hepatoblastoma lesion.
ICG sensitivity during thoracotomy was 95% for hepatoblastoma detection.
ICG sensitivity during thoracoscopic surgery was 74% for hepatoblastoma detection.
ICG sensitivity for primary hepatoblastoma was 94%.
ICG sensitivity for relapsed hepatoblastoma was 73%.
ICG sensitivity was 92% for 25 resected liver specimens from nine patients with all parenchymal margins grossly negative for disease.
Four multifocal hepatoblastoma lesions were identified with ICG, with two resected solely by ICG-avidity.
ICG is a sensitive adjunct for identifying local and metastatic hepatoblastoma, including lesions not visualized on preoperative imaging.
ICG assists in delineating margins during liver resection for hepatoblastoma.
False positives limit ICG specificity in hepatoblastoma surgery.